glp-1 digital health platform startups research2guidance Market Overview: GLP-1 Agonists and
Description
and Lu Ann Williams, global senior vice president and co-founder, Innova Market Insights, as they discuss the effects of a greater demand for nutrient density on the demand for protein
It also has a longer half-life, meaning it stays active in the body for a longer period, which leads to more sustained appetite suppression and better blood sugar control
The story of GLP-1 fits perfectly within this
[DOI] [PubMed] [Google Scholar] 27.Unger R.H., Ohneda A., Valverde I., Eisentraut A.M., Exton J
Back Samols, E, Marri, G, Marks, V (1965) Promotion of insulin secretion by glucagon, Lancet , 40, 415-6
